Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making
Podcast 4: Patient-Centered Treatment Selection in UC
Post-Test/Evaluation

Questions marked with a * are required

20%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

A 28-year-old male with a 4-year history of left-sided ulcerative colitis was treated with prednisone taper and azathioprine at diagnosis, but at 6 months had recurrent flare and initiated infliximab. He achieved and maintained clinical and endoscopic remission for 5 years on infliximab but has now returned to his gastroenterologist with recurrent flare symptoms including frequent loose, bloody stools, bowel urgency, and occasional fecal incontinence. He has expressed his preference for an orally dosed medication as he has a fear of needles. Given the patient’s goals and preferences which of the following treatment options would be most appropriate?

Switch to vedolizumab

Switch to ozanimod

Switch to ustekinumab

None of the above

In the context of patient-centered decision making for therapy selection in ulcerative colitis, which of the following factors is considered the most important?

Potential side effects

Cost

The patient’s understanding of the disease and therapy

Disease severity